FDA approves combination therapy for chronic hepatitis C infection

被引：0

|

作者：

不详

机构：

来源：

LABORATORY MEDICINE | 2001年 / 32卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：480 / 481

页数：2

相关论文

共 50 条

[1] FDA approves treatment for chronic hepatitis B
不详
LABORATORY MEDICINE, 2002, 33 (11) : 829 - 829
[2] FDA Approves Sovaldi for Chronic Hepatitis C (Drug Is Third With Breakthrough Therapy Designation to Receive Such Approval)
不详
CLINICAL INFECTIOUS DISEASES, 2014, 58 (05) : I - I
[3] FDA approves first combination vaccine for hepatitis A and B
不详
CLINICAL INFECTIOUS DISEASES, 2001, 33 (01) : II - II
[4] FDA approves broad hepatitis C treatment
Mushtaq, Ammara
LANCET INFECTIOUS DISEASES, 2016, 16 (10): : 1118 - 1119
[5] Combination therapy for hepatitis C infection
Liang, TJ
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1549 - 1550
[6] Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection
Battaglia, AM
Hagmeyer, KO
ANNALS OF PHARMACOTHERAPY, 2000, 34 (04) : 487 - 494
[7] Combination therapy for chronic hepatitis C
Zeuzem, S
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (08) : 370 - 374
[8] Combination therapy for chronic hepatitis C
Marcellin, P
ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (02): : 135 - 136
[9] US FDA approves boceprevir for treatment of hepatitis C
不详
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (07) : 763 - 763
[10] Combination therapy for hepatitis C infection - Reply
Davis, GL
McHutchison, TG
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15): : 1208 - 1208

← 1 2 3 4 5 →